Protagonist Therapeutics shares owned by UBS Group
Quarter-by-quarter ownership of Protagonist Therapeutics (PTGX) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Protagonist Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Protagonist Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Protagonist Therapeutics by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $126M | 1.9M | 66.43 |
| 2025-06-30 | $138M | 2.5M | 55.27 |
| 2025-03-31 | $17M | 353k | 48.36 |
| 2024-12-31 | $5.1M | 133k | 38.60 |
| 2024-09-30 | $3.5M | 79k | 45.00 |
| 2024-06-30 | $2.3M | 67k | 34.65 |
| 2024-03-31 | $5.1M | 178k | 28.93 |
| 2023-12-31 | $3.5M | 151k | 22.93 |
| 2023-09-30 | $1.5M | 91k | 16.68 |
| 2023-06-30 | $1.8M | 66k | 27.62 |
| 2023-03-31 | $2.7M | 116k | 23.00 |
| 2022-12-31 | $2.5M | 226k | 10.91 |
| 2022-09-30 | $393k | 47k | 8.44 |
| 2022-06-30 | $1.1M | 129k | 8.51 |
| 2022-03-31 | $2.9M | 123k | 23.68 |
| 2021-12-31 | $2.3M | 66k | 34.20 |
| 2021-09-30 | $1.2M | 69k | 16.92 |
| 2021-06-30 | $120k | 2.7k | 44.74 |
| 2021-03-31 | $1.2M | 45k | 25.89 |
| 2020-12-31 | $1.3M | 65k | 20.73 |
| 2020-09-30 | $1.1M | 55k | 19.55 |
| 2020-06-30 | $1.2M | 69k | 17.66 |
| 2020-03-31 | $517k | 73k | 7.06 |
| 2019-12-31 | $149k | 21k | 7.04 |
| 2019-09-30 | $200k | 17k | 12.03 |
| 2019-06-30 | $1.3M | 104k | 12.11 |
| 2019-03-31 | $21k | 1.6k | 12.77 |
| 2018-12-31 | $11k | 1.9k | 6.00 |
| 2018-09-30 | $73k | 7.1k | 10.35 |
| 2018-06-30 | $276k | 41k | 6.73 |
| 2017-12-31 | $8.0k | 388 | 20.62 |
| 2017-09-30 | $5.0k | 309 | 16.18 |
| 2017-06-30 | $19k | 1.7k | 11.37 |
| 2017-03-31 | $4.0k | 329 | 12.16 |
| 2016-12-31 | $32k | 1.4k | 22.18 |
| 2016-09-30 | $23k | 1.1k | 21.52 |